Adherence with advice and prescriptions in SLE is mostly good,but better follow up is needed: A study with a questionnaire

Abstract

The objective was to evaluate the efficacy of the information policy given to all systemic lupus erythematosus (SLE) patients. One hundred consecutive SLE patients were asked to answer anonymously a questionnaire covering demographic issues including education, adherence with prescriptions and advice given and methods of sourcing information. Seventy-three females and ten males responded. The demographic data showed that 34 had a university education, 29 high school and 19 primary school education. An inability to work due to disease was increased compared with the matched population (P < 0.001). Forty-two reported that they had received advice about physical training and forty of them followed this advice. Only 28 out of 46 smokers reported that they had got any advice about smoking, and out of these only 13 followed the advice. The patients with university background were less likely to smoke (P < 0.05) and followed the advice more often (P < 0.05). Most patients followed given advice about exposure to sunlight. Thirty-five percent of those prescribed glucocorticoids reported that they varied from the prescribed dosages without consultation with their specialist. This behaviour was more common in the university group (P < 0.05), this grouping also had a higher median dosage. Seventy-three patients had read the booklet about SLE provided by the clinic. Accessing internet information was more common for those with university education (P < 0.01). This study shows that on the whole SLE patients follow given advice, but adherence varies. Aside from the issue of glucocorticoid dosage adherence, educational level seems to be the most important predictor for adherence to advice. Thus, we conclude that a more individualized approach to delivery of information is required and better follow up is needed. Lupus (2007) 16, 701—706.

Keywords

adherence BMI education glucocorticoids lifestyle SLE sunscreen

Get full access to this article

View all access options for this article.

References

Nived O. , Sturfelt G. Epidemiology of systemic lupus erythematosus. Monogr Allergy 1987; 21: 197—214.

Hochberg MC Systemic lupus erythematosus. Rheum Dis Clin North Am 1990; 16: 617—639.

Urowitz MB , Gladman DD , Abu-Shakra M. , Farewell VT Mortality studies in systemic lupus erythematosus. Results from a single center III. Improved survival over 24 years. J Rheumatol 1997; 24: 1061—1065.

Uramoto KM , Michet CJ Jr , Thumboo J. , Sunku J. , O'Fallon WM , Gabriel SE Trends in the incidence and mortality of systemic lupus erythematosus, 1950—1992 . Arthritis Rheum 1999; 42: 2021—2022.

Urowitz MB , Bookman AA , Koehler BE , Gordon DA , Smythe HA , Ogryzlo MA The bimodial mortality pattern of systemic lupus erythematosus. Am J Med 1976; 60: 221—225.

Trager J. , Ward MM Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001; 13: 345—351.

Björnådal L. , Yin L. , Granath F. , Klareskog L. , Ekbom A. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964—95. J Rheumatol 2004; 31: 713—719.

Kannel WB , Castelle WP , Gordon T. , Mc Namara PM. Serum, lipoproteins and the risk of coronary artery disease . Ann Intern Med 1971; 74: 1—12.

D'Agostino RB Sr , Grundy S. , Sullivan LM , Wilson P. , CHD risk Prediction Group. Validation of the Framingham coronary hearth disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286: 180—187.

10.

Aranow C. , Ginzler EM Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 2000; 9: 166—169.

11.

Roman MJ , Shanker BA , Davis A. et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399—2406.

12.

Bruce IN , Urowitz MB , Gladman DD , Ibanez D. , Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the toronto risk factor study. Arthritis Rheum 2003; 48: 3159—3167.

13.

Bessant R. , Hingorani A. , Patel L. , MacGregor A. , Isenberg DA , Rahman A. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology ( Oxford) 2004; 43: 924—929.

14.

Frostegård J. SLE, atherosclerosis and cardiovascular disease . J Intern Med 2005; 257: 485—495.

15.

Petri M. , Perez-Gutthann S. , Spence D. , Hochberg MC Risk factors for coronary artery disease in patients with systemic lupus erythematosus . Am J Med 1992; 93: 513—519.

16.

McGregor AJ , Dhillon VB , Binder A. et al. Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 152—155.

17.

Rahman P. , Gladman DD , Urowitz MB et al. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. J Rheumatol 1999; 26: 325—330.

18.

Wallace DJ , Metzger AL , Stecher VJ et al. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic diseases: reversal of of deleterious effects of steroids on lipids. Am J Med 1990; 89: 322—326.

19.

Jonsson H. , Nived O. , Sturfelt G. , Silman A. Estimating the incidence off systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol 1990; 29: 185—188.

20.

Costenbader KH , Karlson EW , Gall V. et al. Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus. Arthritis Rheum 2005; 53: 718—723.

21.

Jönsen A. , Bengtsson AA , Nived O. , Ryberg B. , Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology 2002; 41: 1308—1312.

22.

Partridge AJ , Karlsson EW , Daltroy LH et al. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum 1997; 40: 2199—2206.

23.

Mau W. , Listing J. , Huscher D. , Zeidler H. , Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005; 32: 571—574.

24.

Scholte Op Reimer W. , de Swart E. , De Bacquer D. et al. Smoking behaviour in European patients with established coronary heart disease. Eur Heart J 2006; 27: 35—41.

25.

Lin WE , Yang WS , Lin HY Prednisolone non-compliance and its related factors in patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi ( Taipei) 1995; 56: 244—251.

26.

Garcia Popa-Lissenau MG , Greisinger A. , Richardson M. et al. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic diseases. J Rheumatol 2005; 32: 913—919.

27.

Sundaramurthy S. , Bush TM , Neuwelt CM , Ward MM Time perspective predicts the progression of permanent organ damage in patients with systemic lupus erythematosus. Lupus 2003; 12: 443—448.

28.

Rahman P. , Gladman DD , Urowitz MB Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus . J Rheumatol 1998; 25: 1712—1719.

29.

Vila LM , Mayor AM , Valentin AH et al. Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. P R Health Sci J 1999; 18: 89—94.

30.

Branström R. , Brandberg Y. , Holm L. , Sjöberg L. , Ullen H. Beliefs, knowledge and attitudes as predictors of sunbathing habits and use of sun protection among Swedish adolescents. Eur J Cancer Prev 2001;10: 337—345.

31.

Nilsson M. , Trehn G. , Asplund K. Use of complementary and alternative medicine remedies in Sweden. A population-based longitudinal study within northern Sweden MONICA project. Multinational monitoring of trends and determinants of cardiovascular disease. J Intern Med 2001; 250: 225—233.

32.

Upchurch DM , Chyu L. Use of complementary and alternative medicine among American women. Womens Health Issues 2005; 15: 5—13.

33.

Sleath B. , Callahan L. , De Vellis RF , Sloane PD Patients' perceptions of primary care physicians' participatory decision-making style and communication about complementary and alternative medicine for arthritis . J Altern Complement Med 2005; 11: 449—453.

34.

Hearth-Holmes M. , Murphy PW , Davis TC et al. Literacy in patients with a chronic disease: systemic lupus erythematosus and the reading level of patient education materials. J Rheumatol 1997; 24: 2335—2339.